EUVIMEDEUVIMED entdecken
BeobachtungsstudieKohortenstudieOpen Access · CC BY 4.0

Cerebrospinal fluid levels of the macrophage-specific biomarker sCD163 are diagnostic for Lyme neuroborreliosis: An observational cohort study

Mathilde Ørbæk, Rosa Maja Møhring Gynthersen, Helene Mens, Christian Brandt, Christian Stenør, Lothar Wiese, Åse Bengaard Andersen, Holger J Møller, Anne-Mette Lebech

Clinica Chimica Acta · 2023

DOI: 10.1016/j.cca.2023.117299 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Clinica Chimica Acta, 2023. Verfasst von Mathilde Ørbæk und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark; Cluster for Molecular Imaging, Department of …. Hauptthemen laut MEDLINE: Lyme Neuroborreliosis, Nervous System Diseases, Meningitis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: A P Møller Mærsk A S, Interreg Europe, Lundbeckfonden.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: We aimed to investigate levels of the macrophage-specific marker, sCD163, in cerebrospinal fluid and plasma in patients with Lyme neuroborreliosis. We tested the diagnostic value of CSF-sCD163 and ReaScan-CXCL13 and analyzed if plasma-sCD163 could monitor treatment response. METHODS: An observational cohort study: Cohort 1-Cerebrospinal fluid from adults with neuroborreliosis (n = 42), bacterial meningitis (n = 16), enteroviral meningitis (n = 29), and controls (n = 33); Cohort 2-Plasma from 23 adults with neuroborreliosis collected at diagnosis, three, and six months. sCD163 was determined using an in-house sandwich ELISA. ReaScan-CXCL13 measured semiquantitative concentrations of CXCL13, cut-off ≥ 250 pg/ml diagnosed neuroborreliosis. Receiver Operating Characteristics analyzed the diagnostic strength. A linear mixed model including follow-up as categorical fixed effect analyzed differences in plasma-sCD163. RESULTS: CSF-sCD163 was higher in neuroborreliosis (643 µg/l) than in enteroviral meningitis (106 µg/l, p < 0.0001) and controls (87 µg/l, p < 0.0001), but not bacterial meningitis (669 µg/l, p = 0.9). The optimal cut-off was 210 µg/l, area under the curve (AUC) 0.85. ReaScan-CXCL13 had an AUC of 0.83. Combining ReaScan-CXCL13 with CSF-sCD163 increased AUC significantly to 0.89. Plasma-sCD163 showed little variation and was not elevated during the 6 months of follow-up. CONCLUSION: CSF-sCD163 is diagnostic for neuroborreliosis with an optimal cut-off of 210 µg/l. Combining ReaScan-CXCL13 with CSF-sCD163 increases AUC. Plasma-sCD163 cannot monitor treatment response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lyme NeuroborreliosisNervous System DiseasesMeningitisAdultHumansROC CurveCohort StudiesBiomarkersCerebrospinal Fluid

Stichwörter der Autor:innen

BiomarkerBorrelia burgdorferi sensu latoDiagnosticsLyme neuroborreliosissCD163

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark; Cluster for Molecular Imaging, Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark. El…
  • Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Department of Pulmonary and Infectious Diseases, Nordsjællands University Hospital, Hillerød, Denmark; Department of Infectious Diseases, Sjællands University Hospital, Roskilde, Denmark.
  • Department of Neurology, Copenhagen University Hospital, Herlev, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
  • Department of Infectious Diseases, Sjællands University Hospital, Roskilde, Denmark.
  • Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Förderung

  • A P Møller Mærsk A S
  • Interreg Europe
  • Lundbeckfonden
  • Rigshospitalet

Zitieren

APA

Ørbæk, M., Gynthersen, R. M. M., Mens, H., Brandt, C., Stenør, C., Wiese, L., Andersen, Å. B., Møller, H. J., & Lebech, A. M. (2023). Cerebrospinal fluid levels of the macrophage-specific biomarker sCD163 are diagnostic for Lyme neuroborreliosis: An observational cohort study. Clinica Chimica Acta. https://doi.org/10.1016/j.cca.2023.117299

Vancouver

Ørbæk M, Gynthersen RMM, Mens H, Brandt C, Stenør C, Wiese L, et al. Cerebrospinal fluid levels of the macrophage-specific biomarker sCD163 are diagnostic for Lyme neuroborreliosis: An observational cohort study. Clinica Chimica Acta. 2023. doi:10.1016/j.cca.2023.117299

BibTeX
@article{rbk2023,
  author = {Ørbæk, Mathilde and Gynthersen, Rosa Maja Møhring and Mens, Helene and Brandt, Christian and Stenør, Christian and Wiese, Lothar and Andersen, Åse Bengaard and Møller, Holger J and Lebech, Anne-Mette},
  title = {Cerebrospinal fluid levels of the macrophage-specific biomarker sCD163 are diagnostic for Lyme neuroborreliosis: An observational cohort study},
  journal = {Clinica Chimica Acta},
  year = {2023},
  doi = {10.1016/j.cca.2023.117299}
}
Kostenlos starten →